Sangamo Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. Welcome to Barclays Global Healthcare Conference. My name is Gena Wang. I'm a SMid Cap Biotech Analyst. It is my great pleasure to introduce our next presenting company, Sangamo Therapeutics. With us today, we have Sandy Macrae, Chief Executive Officer.
Thank you, Gina. It's such a pleasure to be back out in the world and to be here with Gina in Miami and to talk to you about Sangamo.
As always, we refer you to our forward-looking statements. Sangamo is a fascinating company. We believe we have been a pioneer in the genomic medicines. We believe that we have compelling clinical data, scientific tool kit and the manufacturing infrastructure that is essential to underpin any genomic medicine company.
And we've been on a remarkable journey from the company the first pioneer at editing of cells, editing in vitro, editing in vivo to the first-generation Sangamo, where I'm
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
